|

Parkinson's Disease Clinical Trials in Chicago, IL

17 recruiting studies within 50 miles

Phase
Trial Phase Dist.
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's DiseasePhase 32 mi
Use of CereGate Therapy for Freezing of Gait in PDN/A2 mi
A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)Phase 22 mi
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's DiseasePhase 32 mi
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry—2 mi
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's DiseasePhase 22 mi
A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Thalamotomy for the Treatment of Medication-Refractory Tremor Dominant Idiopathic Parkinson's Disease—2 mi
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's DiseasePhase 2/32 mi
rTMS to Improve Cognition in Parkinson'sPhase 1/22 mi
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort—2 mi
Parkinson's Foundation PD GENEration Genetic Registry—2 mi
Black and African Americans Connections to Parkinson's Disease (BLAAC PD)—2 mi
Pimavanserin vs. Quetiapine for Treatment of Parkinson's PsychosisPhase 411 mi
Non-invasive VNS for Parkinson's GaitN/A11 mi
A Digital Therapeutic Platform for Swallowing and Drooling Problems in Parkinson'sPhase 312 mi
A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications—27 mi
A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's DiseasePhase 427 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.